Reportlinker Adds Paget's Disease - Drug Pipeline Analysis and Market Forecasts to 2016

NEW YORK, March 16 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Paget's Disease - Drug Pipeline Analysis and Market Forecasts to 2016

http://www.reportlinker.com/p0182978/Paget's-Disease---Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html

Description

Paget's Disease - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

"Paget's Disease – Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global Paget's disease market. The report identifies the key trends shaping and driving the global Paget's disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global Paget's disease sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

<bScope

The <bScope of the report includes:

- Annualized global Paget's disease revenues data from 2001 to 2009, forecast forward for 7 years to 2016.

- Geographic markets covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France, and Japan.

- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.

- Analysis of the current and future market competition in the global Paget's disease.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for the future market associated with Paget's disease.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global Paget's disease market.

- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global Paget's disease market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What's the next big thing in the global Paget's disease market landscape? – Identify, understand and capitalize.

Companies Mentioned

Merrion Pharmaceuticals

Table of Contents

1 Table of contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Paget's Disease: Market Characterization 4

2.1 Overview 4

2.2 Paget's Disease Market Size 4

2.3 Paget's Disease Market Forecast and CAGR 5

2.4 Drivers and Barriers for the Paget's Disease Market 6

2.4.1 Drivers for the Paget's Disease Market 6

2.4.2 Barriers of the Paget's disease Market 7

2.5 Opportunity and Unmet Need 7

2.6 Key Takeaway 8

3 Paget's Disease Market: Competitive Assessment 9

3.1 Overview 9

3.2 Strategic Competitor Assessment 9

3.3 Product Profile for the Major Marketed Products in the Paget's Disease Market 10

3.3.1 Risedronate (Actonel) 10

3.3.2 Alendronate sodium (Fosamax) 11

3.3.3 Zoledronic Acid (Reclast/Aclast) 12

3.3.4 Pamidronate Disodium (Aredia) 13

3.3.5 Etidronate Disodium (Didronel) 14

3.3.6 Tiludronate disodium (Skelid) 15

3.4 Key Takeaway 16

4 Paget's Disease: Pipeline Assessment 17

4.1 Overview 17

4.2 Strategic Pipeline Assessment 17

4.2.1 Technology Trends Analytic Framework 17

4.3 Paget's disease Therapeutics – Promising Drugs under Clinical Development 18

4.4 Drugs under Clinical Development 18

4.4.1 Orazol 18

4.4.2 sFRP-1 19

4.5 Paget's disease Therapeutics Market – Clinical Pipeline by Mechanism of Action 19

4.6 Paget's Disease Pipeline – Pipeline by Clinical Phases of Development 20

4.6.1 Paget's Disease Therapeutics – Phase II Clinical Pipeline 20

4.6.2 Paget's Disease Therapeutics – Preclinical Pipeline 20

4.7 Discontinued / Suspended Drugs for Paget's Disease 21

4.8 Key Takeaway 21

5 Paget's Disease Market: Implications for Future Market Competition 22

6 Paget's disease Market: Future Players in the Paget's Disease Market 23

6.1 Introduction 23

6.2 Merrion Pharmaceuticals 23

6.2.1 Overview 23

6.2.2 Product Description 23

6.2.3 Marketed Products 24

6.2.4 Pipeline of Merrion Pharmaceuticals 24

7 Paget's disease Market: Appendix 25

7.1 Market Definitions 25

7.2 Abbreviations 25

7.3 Research Methodology 25

7.3.1 Coverage 26

7.3.2 Secondary Research 26

7.3.3 Forecasting 26

7.3.4 Primary Research 29

7.3.5 Expert Panels 29

7.4 Contact Us 29

7.5 Disclaimer 29

7.6 Sources 30

List of Tables

1.1 List of Tables

Table 1: Global Paget's Disease Market Revenue ($m), 2001-2009 5

Table 2: Global Paget's Disease Market Forecasts ($m), 2009-2016 6

Table 3: Phase III Results of a Pooled Comparison of Zoledroante and Risedronate in Patients with Paget's Disease 11

Table 4: Major Marketed Products in the Paget's Disease Market, 2010 16

Table 5: Paget's Disease Therapeutics – Promising Drugs Under Clinical Development, 2010 18

Table 6: Paget's Disease Therapeutics – Phase II Clinical Pipeline, 2010 20

Table 7: Paget's Disease Therapeutics – Preclinical Pipeline, 2010 20

Table 8: List of Discontinued Drugs for Paget's Disease, 2010 21

Table 9: Merrion Pharmaceuticals – Pipeline, 2010 24

List of Figures

1.2 List of Figures

Figure 1: Global Paget's Disease Market Revenue ($m), 2001-2009 5

Figure 2: Global Paget's Disease Market Forecasts ($m), 2009-2016 6

Figure 3: Opportunity and Unmet Need in the Paget's Disease Market, 2010 8

Figure 4: Strategic Competitor Assessment of the Major Marketed Products in Paget's Disease, 2010 10

Figure 5: Technology Trends Analytic Framework of the Paget's Disease Pipeline, 2010 17

Figure 6: Technology Trends Analytic Framework of Paget's Disease Pipeline – Description, 2010 18

Figure 7: Paget's Disease Therapeutics Market – Clinical Pipeline by Mechanism of Action, 2010 20

Figure 8: Paget's Disease Pipeline by Phase of Clinical Development, 2010 20

Figure 9: Implications for Future Market Competition in the Paget's Disease Market, 2010 22

Figure 10: Paget's Disease Therapeutics Market – Clinical Pipeline by Company, 2010 23

Figure 11: GlobalData Methodology, 2010 25

Figure 12: GlobalData Market Forecasting Model 28

To order this report:

Pharmaceutical Industry: Paget's Disease - Drug Pipeline Analysis and Market Forecasts to 2016

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker

21%

more press release views with 

Request a Demo